Skip to content

FastWave Medical Secures Four New International Patents

FastWave Medical has secured four new patents in Australia and Japan for its Artero™ E-IVL and Sola™ L-IVL platforms, strengthening its intellectual property portfolio to a total of 13 patents worldwide. This expansion will support the company’s upcoming peripheral and coronary IDE trials as they work towards improving the treatment of calcific artery disease. The advancements in IVL technology aim to address the challenges posed by calcified arterial disease during interventional procedures.

Newly issued patents in Australia and Japan cover the company’s Artero™ E-IVL and Sola™ L-IVL platforms as FastWave advances toward peripheral and coronary IDE trials. MINNEAPOLIS, May 19, 2026 /PRNewswire/ — FastWave Medical has added four international patents to its intellectual…